Matica Bio, VaxDome Partner on Next-Gen Antiviral Vaccines
COLLEGE STATION, Texas, July 6, 2026 Matica Biotechnology, Inc. (Matica Bio) has entered into a strategic partnership with VaxDome...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
COLLEGE STATION, Texas, July 6, 2026 Matica Biotechnology, Inc. (Matica Bio) has entered into a strategic partnership with VaxDome...
NEW YORK, July 6, 2026 DarioHealth Corp. has announced a significant expansion of its digital health platform through a...
New York, USA – May 20, 2026 Enhanced Group, Inc. announced a major update from its Institutional Review Board...
